Showing results (101-110 of 334) with videos related to

Sort By:
Pageof 34
Neurology|June 1, 1984
Severity of Parkinson's disease and the dosage of bromocriptineT A Larsen, R Newman, P LeWitt, et al.
Neurology|October 1, 1981
Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptineT Eisler, R P Hall, K A Kalavar, et al.
Annals of Neurology|November 1, 1993
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonismB J Snow, T G Nygaard, H Takahashi, et al.
Neurology|June 1, 1984
Effortful and automatic memory: effects of dopamineR P Newman, H Weingartner, S A Smallberg, et al.
Neurology|December 1, 1977
Experiences with a new ergoline (CF 25-397) in parkinsonismP F Teychenne, R Pfeiffer, S M Bern, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Local treatment of spasmodic torticollis with botulinum toxinJ K Tsui, R D Fross, S Calne, et al.
Neurology|January 15, 2000
Botulinum toxin A as treatment for drooling saliva in PDP K Pal, D B Calne, S Calne, et al.
Advances in Neurology|January 1, 1993
Clinical heterogeneity of dopa-responsive dystonia: PET observationsH Takahashi, B J Snow, T G Nygaard, et al.
Annals of Neurology|January 1, 1997
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?F J Vingerhoets, M Schulzer, D B Calne, et al.
Pageof 34